Skip to main content
← Companies
CTEV

Claritev Corp

Data as of Sep 17, 2026
CTEV
CIK 1793229

Lobbying

$1,900,000 in reported federal lobbying spend across 22 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Health Issues +1$1M11 filings
  • Health Issues$460K5 filings
  • Health Issues +2$400K5 filings
  • Medicare/Medicaid +2$40K1 filing

Latest filings, Apr 2026 onward

FiledRegistrant and subjectAmount
Jul 20, 2026
ALSTON & BIRD LLP for CLARITEV
Health Issues · Medicare/Medicaid Issues related to healthcare reimbursement; issues related to payment and revenue integrity. Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
$60,000
Jul 17, 2026
CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Health Issues · Medicare/Medicaid Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency Issues related to healthcare reim
$130,000
May 22, 2026
FORBES-TATE for CLARITEV (FKA MULTIPLAN CORPORATION)
Medicare/Medicaid · Labor Issues/Antitrust/Workplace · Health Issues Issues pertaining to payment for healthcare services and healthcare data transparency. Issues related to anti-trust. Issues related to payment for healthcare services; Issues related to healthcare data transparency.
$40,000
Apr 20, 2026
CLARITEV (FORMERLY MULTIPLAN CORPORATION)
Health Issues · Medicare/Medicaid Issues related to healthcare reimbursement; issues related to payment and revenue integrity; and S.2355/HR 5582: Patients Deserve Price Tags Act including issues related to price and coverage transparency Issues related to healthcare reim
$160,000
Apr 20, 2026
ALSTON & BIRD LLP for CLARITEV
Health Issues · Medicare/Medicaid Issues related to healthcare reimbursement; issues related to payment and revenue integrity. Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
$60,000
Apr 17, 2026
FORBES-TATE for CLARITEV (FKA MULTIPLAN CORPORATION)
Health Issues · Medicare/Medicaid · Labor Issues/Antitrust/Workplace Issues related to payment for healthcare services; Issues related to healthcare data transparency. Issues pertaining to payment for healthcare services and healthcare data transparency. Issues related to anti-trust.
$80,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Claritev Corp through its SEC registration (CIK 1793229) and tickers CTEV.

As of: lobbying filings through Jul 20, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.